Navigation Links
Gene therapy prevents the onset of diabetic symptoms in mice

Acid rain, the environmental consequence of burning fossil fuels, running factories and driving cars, has altered soils and reduced the number of sugar maple trees growing in the Northeast, according to a new study led by Cornell University researchers.

The sugar maple is the most economically valuable tree species in the eastern United States because of its high-priced lumber, syrup and tourist-attracting fall colors.

The study, whose lead author, Stephanie Juice '04, was an undergraduate when the research was conducted, suggests that because acid rain makes the soil more acidic, unfavorable conditions are created for sugar maples. In acidic soils, sugar maples produce fewer seedlings that survive and mature, and more adult trees die, the researchers found. They drew these conclusions after adding nutrients to soil in a test plot and reproducing the favorable soil conditions that existed prior to 20th century industrial pollution. The result: Sugar maples on the plot rebounded dramatically.

The study provides "the most conclusive evidence to date" that the decline of sugar maples is linked to the effects of acid rain produced by human activity, said Timothy Fahey, professor of forest ecology at Cornell and co-author of the study, which is published in the May issue of Ecology. Juice wrote the main part of the paper as part of her senior thesis.

"The research addresses how a long-term, human-caused change in the environment is affecting sugar maples, which are valuable both ecologically and economically as one of the dominant species in our region," said Juice, who now works for the Institute of Ecosystem Studies in Milbrook, N.Y., as a project assistant and is applying to the Peace Corps for next year.

The research was conducted at Hubbard Brook Experimental Forest (HBEF), a 3,160-hectare reserve near North Woodstock, N.H., where scientists have measured soil composition for the past 50 years. The scientists added nutrient
'"/>

Source:University of Pittsburgh Medical Center


Page: 1 2 3

Related biology news :

1. Adding Radiation Therapy To Chemotherapy Improves Survival In Patients With High-risk Breast Cancer
2. Columbia research lifts major hurdle to gene therapy for cancer
3. Combination therapy boosts effectiveness of telomere-directed cancer cell death
4. Gene therapy converts dead bone graft to new, living tissue
5. Study identifies predictors of HIV drug resistance in patients beginning triple therapy
6. New imaging method gives early indication if brain cancer therapy is effective, U-M study shows
7. Muscle-targeted gene therapy reverses rare muscular dystrophy in mice
8. New therapy for HIV/AIDS eliminates needles and excessive toxicity
9. New Treatment Rivals Chemotherapy For Lymphoma, Study Finds
10. Gene therapy for Parkinsons disease moves forward in animals
11. Pulsating ultrasound enhances gene therapy for tumors
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Gene therapy prevents the onset diabetic symptoms mice

(Date:7/28/2014)... 28, 2014)The Brain & Behavior Research Foundation today ... Freedman Prizes, recognizing exceptional clinical and basic research ... NARSAD Young Investigator Grants. The grants enable early ... and psychosocial research for the prevention, early detection, ... one in four people. , Six young scientistswinners ...
(Date:7/28/2014)... killers to prevent and treat HIV infection has been ... these molecules can arouse as they get rid of ... the Weizmann Institute and the National Institutes of Health ... molecules interferons around the time of infection ... disease. Their research appeared in Nature . ...
(Date:7/28/2014)... using statistical tools to map social connections in ... observational techniques, shedding light on prairie dog communities ... plague and guide future conservation efforts. The work ... University and the National Evolutionary Synthesis Center (NESCent). ... subject to bubonic plague," says Dr. Jennifer Verdolin, ...
Breaking Biology News(10 mins):The Brain & Behavior Research Foundation names winners of Klerman and Freedman Prizes 2The Brain & Behavior Research Foundation names winners of Klerman and Freedman Prizes 3The Brain & Behavior Research Foundation names winners of Klerman and Freedman Prizes 4Interfering with interferon 2Social network research may boost prairie dog conservation efforts 2
... 15.11.2013/Gteborg, Kiel, Bremerhaven. Ocean acidification impairs digestion in marine ... journal Nature Climate Change . Researchers from Sweden ... sea urchins Strongylocentrotus droebachiensis . The results show ... water. Carbon dioxide (CO2) emissions do not only ...
... 2013)Provocative new research shows that the Plasmodium ... malaria in 2010, may be "rapidly evolving" to overcome the ... of Africans, scientists reported today at the annual meeting of ... In large swaths of sub-Saharan Africa, some ...
... international team of researchers led by the University of ... a new drug for possible use against heart disease, ... of Cardiovascular Sciences and Department of Biochemistry at the ... USA and Italy, have employed a new technique to ...
Cached Biology News:Ocean acidification: Hard to digest 2New research finds potential risk for millions in Africa believed resistant to vivax malaria 2New research finds potential risk for millions in Africa believed resistant to vivax malaria 3New research finds potential risk for millions in Africa believed resistant to vivax malaria 4New technique for developing drugs to treat serious illnesses 2
(Date:7/25/2014)... 2014 Amgen (NASDAQ: AMGN ) ... $0.61 per share dividend for the third quarter of ... 2014, to all stockholders of record as of the ... About Amgen Amgen is committed to unlocking the ... by discovering, developing, manufacturing and delivering innovative human therapeutics. ...
(Date:7/25/2014)... 2014 According to a new market ... - Global Industry Analysis, Size, Share, Growth, Trends and ... is estimated at USD 161,056.5 million in 2014 and ... from 2014 to 2020, to reach an estimated value ... drugs market is witnessing a significant growth due to ...
(Date:7/25/2014)... 2014  Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD ... development and commercialization of a once-daily, oral therapy for ... announced financial results for the period ended June 30, ... , Reported cash and cash equivalents totaling $37.4 million ... 31, 2013.  , Reported a net loss of ...
(Date:7/24/2014)... NY - July 24, 2014 -- Keryx Biopharmaceuticals, Inc. ... the long-term, randomized, active control Phase 3 study of ... phosphate binder, for the treatment of hyperphosphatemia in patients ... study (PhosphatE binding and iRon delivery with FErric CiTrate ... Journal of the American Society of Nephrology ( ...
Breaking Biology Technology:Amgen Announces 2014 Third Quarter Dividend 2Amgen Announces 2014 Third Quarter Dividend 3Biological Drugs Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 2Biological Drugs Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 3Galmed Pharmaceuticals Reports First Half 2014 Financial Results 2Galmed Pharmaceuticals Reports First Half 2014 Financial Results 3Galmed Pharmaceuticals Reports First Half 2014 Financial Results 4Galmed Pharmaceuticals Reports First Half 2014 Financial Results 5Galmed Pharmaceuticals Reports First Half 2014 Financial Results 6Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 2Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 3Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 4
... May 12 MedApps announced today, that,it has ... most innovative companies as,part of Dell,s 2008 Global ... MedApps Mobile Wireless Health Monitoring System helps connect,people ... Failure (CHF) and COPD, with their healthcare providers. ...
... Aton Pharma, Inc., a global,specialty pharmaceutical company, ... with Meizler Biopharma S/A to commercialize,CUPRIMINE(R) and SYPRINE(R) ... Meizler is working to obtain regulatory approval of ... products, and Aton is,committed to making these products ...
... China, May 12 /Xinhua-PRNewswire/ -- China Medicine,Corporation ... "the Company"),a leading distributor and developer of ... nutritional and,dietary-supplements, medical devices, and medical formulations ... reported solid financial results,for the first quarter ...
Cached Biology Technology:MedApps Selected as Dell-NFIB 2008 Business Excellence Award Finalist 2MedApps Selected as Dell-NFIB 2008 Business Excellence Award Finalist 3Aton Pharma Announces Distribution Partnership in Brazil 2China Medicine Announces Solid First Quarter 2008 Results 2China Medicine Announces Solid First Quarter 2008 Results 3China Medicine Announces Solid First Quarter 2008 Results 4China Medicine Announces Solid First Quarter 2008 Results 5China Medicine Announces Solid First Quarter 2008 Results 6China Medicine Announces Solid First Quarter 2008 Results 7China Medicine Announces Solid First Quarter 2008 Results 8China Medicine Announces Solid First Quarter 2008 Results 9China Medicine Announces Solid First Quarter 2008 Results 10
... Cell Invasion Assay is designed to determine ... as a significant barrier to invasion or ... in a convenient, high-throughput, 96-well format. The ... all types of adherent cells such as ...
... design in ice/water bath This CLS ... created to easily match Cornings product ... please order under the old Sigma-Aldrich ... for assistance. ID clarifier: rack and ...
Membrane Proteins from over 50 different human Alzheimer, Diabetic, Liver Cirrhosis, and Lupus diseased tissues are available....
... This CLS number is ... to easily match Cornings product ... yet, please order under the ... contact customer service for assistance. ...
Biology Products: